Articles written specifically for the GLP or articles that are reposted from other sources (sometimes in modified form) by agreement or with permission list the source as Genetic Literacy Project. Excerpted articles posted in our Daily Digests are identified as excerpts of posts culled from the web. Each Daily Digest post lists the original media outlet as the source next to the name of the author. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair use policy for posting excerpts and using images is explained here.
walmart testing site imgcache rev ed fc d ddde ee ddcaf

Viewpoint: We can’t simply test our way out of the coronavirus pandemic

Michael Hochman | STAT | 
In response to calls for Covid-19 testing of the entire U.S. population, several large universities, and even some employers, have ...
parkinsonssyringegreen illustration mollyferguson

Experimental Parkinson’s treatment draws ethics scrutiny with wealthy donor selected as first patient

Sharon Begley | STAT | 
A secretive experiment revealed [May 12], in which neurosurgeons transplanted brain cells into a patient with Parkinson’s disease, made medical ...

Pandemic could give a boost to remote-monitoring devices that keep patients out of the doctor’s office

Erin Brodwin | STAT | 
It was a shift that began long before the pandemic: Tech companies, health providers, and patients alike were increasingly looking ...
possibilities for stem cell therapy in parkinsons highlighted

‘This is what it feels like to be normal’: Experimental stem cell treatment shows promise against Parkinson’s

Sharon Begley | STAT | 
[Researchers planned] to carry out an experimental transplant surgery unprecedented in the annals of medicine: replacing the dysfunctional brain cells ...
corona vaccine mc de f f f c d

There will be no vaccine widely available by fall (or anytime soon) even with a miracle breakthrough

Helen Branswell | STAT | 
Vaccines to prevent Covid-19 infection are hurtling through development at speeds never before seen. But mounting promises that some vaccine ...
hiv doc x

What the porn industry can teach us about how to live safely with coronavirus

Usha McFarling | STAT | 
Since the late 1990s, when an outbreak of HIV infections threatened to shutter the multibillion-dollar industry, the mainstream porn community ...
prosthesis x

Is this brain-controlled prosthetic arm—with the sensation of touch—the future of prosthetics?

Shafaq Zia | STAT | 
[T]hree years ago, [electrician Rickard] Normark received a new kind of brain-controlled prosthetic that was surgically attached to the bone, ...
clinical trial finder custom@ x

‘Impenetrable medical jargon’: Why retooling should be a priority

Alison Bateman-House, Jamie Webb | STAT | 
Millions of people visit each year to find a trial that they or a loved one might be eligible ...
life care center washington coronavirus ew p d cb e ff a a d b fit w

Viewpoint: US failure to ‘study drugs more quickly’ means more people are dying from coronavirus

Matthew Herper | STAT | 
When medical historians look back at the Covid-19 pandemic, they will reckon with how the United States, with its vast ...
mzu mzu nw

Using artificial intelligence to identify promising coronavirus treatments

Casey Ross | STAT | 
Treating patients with the never-before-seen Covid-19 is forcing doctors to choose between two equally unpalatable options: try an unproven therapy ...
remdesivir image x

Gilead’s remdesivir offers little benefit for coronavirus patients in early trial

The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from ...

When will experimental coronavirus drugs will be ready for the clinic?

Matthew Herper | STAT | 
Is there hope that something will be available soon to help us fight this virus, known as SARS-CoV-2? Here’s a ...
screenshot bioterrorism how real is the threat

Dark side of CRISPR: Rogue scientists could design something nastier than the coronavirus

Neal Baer | STAT | 
When we’ve emerged on the other side of the pandemic, Covid-19 will someday make a good story. But I worry ...
e cab bd db d cdd da

Dealing with ‘confusing directives’, US doctors seek coronavirus advice from Chinese counterparts

Sharon Begley | STAT | 
Now, fed up with what they see as inadequate and confusing directives from public health authorities, many physicians are trying ...
igi covid testing px

CRISPR pioneer Jennifer Doudna turns lab into coronavirus test center

Matthew Herper | STAT | 
A team of academic and industry researchers led by Jennifer Doudna, the researcher best known for her role in the ...
b a a c ea ef ed

Viewpoint: We’re making big decisions on the coronavirus without solid data

John Ioannidis | STAT | 
At a time when everyone needs better information, from disease modelers and governments to people quarantined or just social distancing, ...
when to stop treatment

Coronavirus immunotherapy could arrive by early summer. Is ‘record time’ fast enough?

Maggie Fox | STAT | 
Blood-plasma-based cures aren’t just the stuff of movies. There’s plenty of science to back the idea that blood products from ...
www usnews com

Some countries have done a much better job fighting the coronavirus. Here’s what worked.

Helen Branswell | STAT | 
With Europe and the United States locked in deadly battle with the coronavirus that causes Covid-19, a number of countries ...
blood test

Hunting for DNA signatures in blood could offer early warning system for cancer

Rebecca Robbins | STAT | 
The many companies developing liquid biopsies to try to detect cancer early have so far largely mined the blood in ...
b mu vwtrqwdrhjc

Viewpoint: Promise of genomics and precision medicine a ‘wave of hype without substance’

Nigel Paneth, Richard Cooper | STAT | 
An undeclared civil war is breaking out in biomedicine. On one side is precision medicine, with its emphasis on tailoring treatments ...

Viewpoint: Embracing biosimilars will drive down prices, increase access to drugs

Sean McGowan | STAT | 
The biosimilar category holds incredible promise, and the market for these products is on an upward trajectory. But it’s been ...
screen shot at am

There was an opioid epidemic 130 years ago. Can it teach us anything about today’s crisis?

Haider Warraich | STAT | 
The 1890s and 1990s were both characterized by unopposed amplification of the benefits of opioids, the transformation of physicians into ...
fda signage

Viewpoint: 4 ways the FDA must evolve to deal with fast-moving technologies and health threats

Ellen Sigal, Mark McClellan | STAT | 
As we look toward the FDA of the 2020s that can achieve further progress in addressing urgent health threats and ...

Is the quest for profits getting in the way of ending the HIV epidemic?

Four decades after the HIV epidemic began, there’s finally hope it might end. Indeed, “Getting to Zero” — meaning zero ...
vaccination needle ouch diabetes flu shot medical x

Those childhood vaccinations for tetanus and diphtheria should cover you for life, study says

Elizabeth Cooney | STAT | 
People who got all their vaccinations against tetanus and diphtheria in childhood don’t need booster shots to remain protected against ...

Seeking new momentum in Alzheimer’s research after decades of slow progress

Andrew Joseph | STAT | 
5.8 million Americans have Alzheimer’s, with a new person developing the condition about every minute of every day. There is still ...
human cloning

‘A real mystery’: Why hasn’t anyone attempted to make a cloned human baby?

Henry Greely | STAT | 
For nearly seven years, then, the scientific community has had solid proof that human embryos can be cloned. ...  So ...
blog the horsemen of aging

Viewpoint: We still haven’t agreed on the definition of biological aging. That needs to change

Patti Neighmond | STAT | 
I’ve been committed to understanding the biology of aging since I was a teenager, and my education and career took ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists